Evidence map›Paper›PMID 37829012›Full record

ArticleChemical science2023

π-Extended benzo[1,2:4,5]di[7]annulene bis(dicarboximide)s - a new class of non-alternant polycyclic aromatic dicarboximides.

Jonas Spengler, Chongwei Zhu, Kazutaka Shoyama, Frank Würthner

Abstract read
In one paragraph

Article in Chemical science, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Chiral Heptagon-Embedded Double [6]Helicenes via Scholl Reaction.Angewandte Chemie (International ed. in English) · 2026
    Article
  2. Bis(azuleno)pentalenes with Six Consecutive Odd-Membered Rings.Angewandte Chemie (International ed. in English) · 2025
    Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Jonas SpenglerUniversität Würzburg, Institut für Organische Chemie and Center for Nanosystems Chemistry Am Hubland 97074 Würzburg Germany wuerthner@uni-wuerzburg.de.ORCID https://orcid.org/0009-0003-3834-188X
Chongwei ZhuUniversität Würzburg, Institut für Organische Chemie and Center for Nanosystems Chemistry Am Hubland 97074 Würzburg Germany wuerthner@uni-wuerzburg.de.
Kazutaka ShoyamaUniversität Würzburg, Institut für Organische Chemie and Center for Nanosystems Chemistry Am Hubland 97074 Würzburg Germany wuerthner@uni-wuerzburg.de.ORCID https://orcid.org/0000-0003-0937-4431
Frank WürthnerUniversität Würzburg, Institut für Organische Chemie and Center for Nanosystems Chemistry Am Hubland 97074 Würzburg Germany wuerthner@uni-wuerzburg.de.ORCID https://orcid.org/0000-0001-7245-0471

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Aromatic dicarboximides are a class of molecules represented by the well-known rylene bis(dicarboximide)s, in particular perylene or naphthalene bis(dicarboximide)s, which show pronounced optoelectronic properties and are applied as color pigments, fluorescent dyes and organic semiconductors. Herein we extend the family of aromatic bis(dicarboximide)s and report the synthesis of the first series of non-alternant aromatic dicarboximides by twofold Pd-catalyzed [5 + 2] annulation. Characterization by UV/vis spectroscopy and cyclic voltammetry (CV) measurements give insight into the optoelectronic characteristics of the hitherto unexplored substance class of heptagon-containing imides. Theoretical studies by nucleus independent chemical shift (NICS) XY-scans and anisotropy of the induced current density (ACID) plots demonstrate the influence of both the non-alternant carbon framework and the imide moieties on aromaticity of the synthesized bisimides.

Identifiers

PMID37829012
PMCPMC10566470

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.